Abstract
In genetic diagnostics testing, what are the boundaries of the global patent problem, and is there a real risk that patents and licensing practices could impede access to tests?
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cytogenetics / legislation & jurisprudence*
-
Genetic Testing / legislation & jurisprudence*
-
Genetics / legislation & jurisprudence*
-
Internationality*
-
Patents as Topic / legislation & jurisprudence*
-
United States